White-hot CAR-T darling Juno Therapeutics (JUNO) is at it again, announcing Thursday that is has inked a massive $727 million deal with Editas Medicine , the gene editing company, for a partnership that will forge three research programs marrying Editas’ technologies, including CRISPR/Cas9, to Juno’s CAR and TCR technologies. Under the terms of the deal, […]

Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time. Achillion will be eligible for milestone payments of up to $1.1 billion related to the development, regulatory approval and sales of the […]

BISHOPS STORTFORD, England, May 14, 2015 /PRNewswire/ — Dotmatics, the leading provider of scientific informatics solutions and services for the pharma, biotech, chemicals, agrochemicals and academia announced today that it has appointed LABINDIA as a distributor in India. LABINDIA will be promoting Dotmatics world-leading scientific informatics solutions and services, including its integrated platform for facilitating […]

CHAPEL HILL, N.C., May 10, 2015 /PRNewswire-USNewswire/ — The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and healthcare company with a legacy of success in developing treatments for HIV, today announced the creation of the […]

NEW BRUNSWICK, N.J., May 7, 2015 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced a first-of-its-kind partnership that enlists a third party to review requests made to the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for compassionate use of its investigational medicines. This new approach will begin as a pilot program focused on […]

(Reuters) – Johnson & Johnson will become the first pharmaceutical company to formally seek advice from outside medical ethicists on “compassionate use” requests, in which desperate patients ask drugmakers to let them take an experimental medication, the company announced on Thursday. The ethicists’ recommendations will be advisory, with J&J making the decision. But the drugmaker […]

(Reuters) – New therapies that clinical data show can eliminate blood cancers such as leukemia and lymphoma in 40 percent to 90 percent of patients may have to be genetically modified to include a switch that shields healthy cells from attack. The therapies could generate tens of billions of dollars in annual sales for drugmakers […]

NEW YORK, May 6, 2015 /PRNewswire-USNewswire/ — JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Eli Lilly and Company, a global leader in diabetes care announced a two-year partnership that will provide $1.8 Million in support of JDRF’s mission to improving the lives of people with T1D. This agreement provides a variety of programs and […]

(Reuters) – Apple Inc and International Business Machine Corp have teamed up with Japan Post Holdings Co to improve caregiver and monitoring services for the elderly in Japan, the companies announced on Thursday. IBM will work with Japan Post to develop iPad software that will enable Japan’s national Post Office Watch service to better monitor […]